BrainCool AB, a European Medical device firm, has received the green light from the Food and Drug Administration to market the IQool™ Warm System in the United States, to be used for thermal regulation to cool and rewarm adult patients when clinically indicated.
Recent data and statistics demonstrate that overall American life expectancy has dropped for the first time in a decade, spurring an urgent and pressing need for the advent and proliferation of medical technology—coupled with scientific progress and laws to encourage innovation.
While the research points to specific factors that have lowered rates of mortality, including increased obesity, long-term unemployment, and a resurgence of chronic diseases, the studies incontrovertibly suggest the critical need to provide enhanced ‘life-saving and life-prolonging’ therapies and treatments.
There is no specific way to address the divergence of issues regarding lowered life expectancy, but there are particular measures that must be undertaken. These include enacting evidence-based policies that spur innovation, and further eliminating any roadblocks to America’s inventors.